Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

13 trials with published results (26%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

8.0%

4 terminated out of 50 trials

Success Rate

89.2%

+2.7% vs benchmark

Late-Stage Pipeline

34%

17 trials in Phase 3/4

Results Transparency

39%

13 of 33 completed with results

Key Signals

13 with results89% success

Data Visualizations

Phase Distribution

45Total
Not Applicable (15)
P 2 (13)
P 3 (8)
P 4 (9)

Trial Status

Completed33
Unknown8
Terminated4
Recruiting4
Active Not Recruiting1

Trial Success Rate

89.2%

Benchmark: 86.5%

Based on 33 completed trials

Clinical Trials (50)

Showing 20 of 20 trials
NCT06720896Phase 2RecruitingPrimary

A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.

NCT07451678Phase 4CompletedPrimary

Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topical Chlorhexidine

NCT07431385Not ApplicableRecruitingPrimary

Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment

NCT06371300Not ApplicableRecruiting

Photobiomodulation With REd vs BluE Light (REBEL)

NCT06400511Phase 3TerminatedPrimary

A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment

NCT05454956Phase 2Completed

Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD

NCT06795165Phase 4CompletedPrimary

Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

NCT06520007Completed

Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction

NCT05629390Phase 3CompletedPrimary

Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

NCT06054217Phase 2Active Not Recruiting

Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex

NCT02386774Not ApplicableCompleted

Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa

NCT04475432Phase 2CompletedPrimary

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

NCT04784091Phase 3CompletedPrimary

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

NCT03926026Phase 2CompletedPrimary

Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis

NCT04675242Phase 2CompletedPrimary

Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis

NCT04858113Not ApplicableUnknownPrimary

Short-term Effects on Tear Film (Baby Shampoo vs Blephasol)

NCT05608980Not ApplicableUnknownPrimary

0.01% Hypochlorous Acid in the Treatment of Blepharitis

NCT05139511Not ApplicableUnknown

Analysis of the Results of Intense Pulsed Light Treatment Previously to Laser Refractive Surgery

NCT05062564Not ApplicableCompleted

Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye

NCT03302273Not ApplicableCompleted

Corneal Epithelial Stem Cells and Dry Eye Disease

Scroll to load more

Research Network

Activity Timeline